Please Wait

Applying Filters...

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Flunixin Meglumine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 1 USDMF, 9 CEP/COS, 7 NDC API, 9 VMF, 9 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

8 FDF Dossiers, 6 Canada, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 2 Finar, 1 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 1 Kerry, 2 Nomisma Healthcare, 1 Pluviaendo, 6 Roquette, 1 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Fillers, Diluents & Binders, 12 Topical, 8 Solubilizers, 6 Thickeners and Stabilizers, 6 Controlled & Modified Release, 4 Parenteral, 4 Film Formers & Plasticizers, 4 Direct Compression, 3 Co-Processed Excipients, 3 Chewable & Orodispersible Aids, 3 Taste Masking, 3 Disintegrants & Superdisintegrants, 2 Coating Systems & Additives, 2 Granulation, 1 Emulsifying Agents